Home
Astrazeneca Pharma India Ltd 52 Week Low

Astrazeneca Pharma India Ltd
NSE: ASTRAZEN
YEARLOW
Key Highlights
- The 52 Week Low of Astrazeneca Pharma India Ltd is ₹ 4050 as of 21 Feb 25 .
Company Fundamentals for Astrazeneca Pharma India Ltd
Market Price of Astrazeneca Pharma India Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
Date | |
---|---|
21 Feb 2025 | 6868.75 |
20 Feb 2025 | 6976.5 |
19 Feb 2025 | 6942.7 |
18 Feb 2025 | 6958 |
17 Feb 2025 | 7030.05 |
14 Feb 2025 | 7096.35 |
13 Feb 2025 | 7410.6 |
12 Feb 2025 | 7494.65 |
11 Feb 2025 | 7466.85 |
10 Feb 2025 | 7535.1 |
Asset Value vs Market Value of Astrazeneca Pharma India Ltd
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Historical Revenue of Astrazeneca Pharma India Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
Historical Revenue of Astrazeneca Pharma India Ltd
Historical Net Profit of Astrazeneca Pharma India Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Astrazeneca Pharma India Ltd
Astrazeneca Pharma India Ltd News Hub
AstraZeneca slumps on recording dismal Q1 performance
Revenue from operations jumped 31.15% year on year (YoY) to Rs 387.52 crore in the quarter ended 30
Read more
08 Aug 24
Astrazeneca Pharma India reports standalone net loss of Rs 11.79 crore in the June 2024 quarter
Net loss of Astrazeneca Pharma India reported to Rs 11.79 crore in the quarter ended June 2024 as ag
Read more
08 Aug 24
Astrazenenca Pharma gets CDSCO nod to import Durvalumab solutions
Durvalumab (IMFINZI) in combination with chemotherapy as neoadjuvant treatment, followed by IMFINZI
Read more
24 Sept 24
Astrazeneca Pharma India Ltd leads gainers in 'A' group
Sapphire Foods India Ltd, Godawari Power & Ispat Ltd, Firstsource Solutions Ltd and National Alumini
Read more
24 Sept 24